SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001552781-16-001559
Filing Date
2016-04-19
Accepted
2016-04-18 21:54:57
Documents
12
Period of Report
2016-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e00241_xtnt-8k.htm 8-K 35974
2 e00241_ex10-1.htm EX-10.1 117925
3 e00241_ex10-2.htm EX-10.2 295004
4 e00241_ex10-3.htm EX-10.3 294767
5 e00241_ex10-4.htm EX-10.4 91316
6 e00241_ex10-5.htm EX-10.5 23295
7 GRAPHIC image_001.jpg GRAPHIC 2155
8 GRAPHIC image_002.jpg GRAPHIC 2453
9 GRAPHIC image_003.jpg GRAPHIC 2644
10 GRAPHIC image_004.jpg GRAPHIC 2794
11 GRAPHIC image_005.jpg GRAPHIC 2307
12 GRAPHIC image_006.jpg GRAPHIC 3472
  Complete submission text file 0001552781-16-001559.txt   882361
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 161577886
SIC: 2836 Biological Products, (No Diagnostic Substances)